Medicine
Renal Replacement Therapy Timing in Acute Kidney Injury
Quick fact
The 2020 STARRT-AKI trial, which studied over 2,900 critically ill patients, found no overall survival difference between early and delayed dialysis, but early dialysis was linked to more adverse events—challenging the 'sooner is always better' assumption.
Why this is interesting
A patient’s kidneys suddenly stop filtering waste—doctors know dialysis is needed, but the biggest debate is: should we start now or wait? Getting it wrong can cost lives, yet starting too early might harm just as much.
Read the full explanation
Understanding Renal Replacement Therapy Timing in Acute Kidney Injury
Think of acute kidney injury (AKI) as a sudden plumbing failure in a house. The kidneys, acting like filters, stop clearing waste and balancing fluids. If the backup becomes life-threatening—like toxic waste flooding the house—you call in a temporary filtration system: renal replacement therapy (RRT), commonly known as dialysis. For a long time, the gut reaction was: the moment we see failure, hook up the dialysis machine. But dialysis isn't a simple switch. It carries risks: low blood pressure, infections from catheters, and complications from the procedure itself. So the question becomes: when exactly is the right time to intervene? Is it better to start early, as soon as the kidneys fail, to prevent further chemical chaos? Or is it better to wait, only dialyzing when severe complications like dangerously high potassium or fluid buildup in the lungs force your hand? This is the timing debate.
A deeper explanation
The decision to start RRT rests on two core factors: clinical urgency and the risk of overtreatment. Absolute indications—severe hyperkalemia, refractory metabolic acidosis, and fluid overload unresponsive to diuretics—demand immediate dialysis. But in many AKI patients, the situation is not so clear-cut. Kidney function might recover spontaneously, and blood markers (like creatinine) can improve without intervention. Starting dialysis early in such cases exposes the patient to unnecessary risks, including catheter-related infections and hemodynamic instability, which can worsen outcomes. Conversely, delaying dialysis in a patient who truly needs it risks life-threatening complications, such as cardiac arrest due to hyperkalemia or respiratory failure from pulmonary edema. Landmark trials have shaped our understanding. The AKIKI trial (2016) found no mortality difference between early and delayed strategies in critically ill patients, with the delayed group often avoiding dialysis altogether. The ELAIN trial (2016) was smaller but suggested early initiation improved survival—in a specific surgical ICU population. The later, larger STARRT-AKI trial (2020) found no overall survival benefit from early initiation, but more adverse events, reinforcing a more conservative approach: vigilant monitoring and only initiating dialysis when clear indications arise. This nuanced picture highlights that timing is a dynamic clinical judgment, balancing potential benefits of early intervention with the harms of overtreatment, and influenced by patient-specific factors and resource availability.